In an article from InvestmentNews.com, June 7, 2011, Bruce Kelly writes that the litigation stemming from a series of oil and gas private placements that failed two years ago have now ensnared a giant in the clearing and custody business, National Financial Services LLC, a unit of Fidelity Investments.

The trustee overseeing the liquidation of assets of Provident Royalties LLC, which the Securities and Exchange Commission charged with fraud in 2009, last month requested that a federal judge in Dallas issue a subpoena to National Financial. In the court filing, the trustee wants access to retirement account documents of clients of four broker-dealers that sold preferred stock of Provident and used National Financial as a clearing firm.

Bruce Kelly writes that dozens of broker-dealers sold the Provident offerings from September 2006 to January 2009, raising $485 million. Regarding National Financial records, the trustee wants documents of 579 clients who bought $39.1 million of Provident from four firms: J.P. Turner & Co. LLC, Milkie/Ferguson Investments Inc.,National Securities Corp. and Securities America, Inc.

A spokesman for National Financial, said the firm typically does not comment on matters involving its correspondent clearing, broker-dealer clients. Clearing firms do not sell securities but rather hold them for broker-dealers and their clients.

The InvestmentNews.com article goes on to say that calling Provident a “massive Ponzi scheme,” the trustee claimed that the “trustee is entitled to information concerning the relationship between the broker-dealers and their respective clearing houses, and how those funds were transferred, paid for and accounted for by the clearing houses,” the court filing stated.

“As custodial fiduciary, [National Financial] should have agreements with the various broker-dealers they did business with and records for every dollar that went through their controlled account,” according to the filing.

Last year the trustee sued dozens of broker-dealers to claw back revenue and commissions from the sale of Provident.

If you feel you have been an alleged victim of these or other broker-dealers and were sold Provident Royalties private placements, call a Securities Arbitration Lawyer for a free consultation on how to potentially recover your losses.  To speak with an attorney, call 888-760-6552, or visit www.stockmarketlawsuit.com.

Soreide Law Group, PLLC., representing investors nationwide before FINRA  the Financial Industry Regulatory Authority.

broker-dealers selling Provident · elder abuse awareness · elder abuse in investments · Fidelity Investments · Financial Industry Regulatory Authority · FINRA · finra lawyer · finra securities arbitration lawyer · fort lauderdale securities fraud lawyer · fort lauderdale securities lawyer · Ft. Lauderdale Securities Lawyer · investment fraud · JP Turner & Company · Milkie/Ferguson Investments Inc · National Financial · National Financial Provident Private Placements · National Financial Services LLC · national securities corporation · oil and gas private placements · oil and gas projects fraud · oil and gas schemes · Ponzi scheme · preferred stock · private placement fraud · private placement losses · private placements · Provident ponzi scheme · Provident preferred stock · Provident Royalties · Provident Royalties LLC · recover losses from ponzi schemes · SEC · Securities America Inc. · Securities and Exchange Commission · securities arbitraton lawyer · securities fraud lawyer · solicit investments in oil and gas · Soreide Law Group PLLC · stock broker fraud · Stock fraud lawyer · stock loss · stockbroker misconduct · targeting elderly investors

In a May 26th., 2011, article from InvestmentNews.com, Bruce Kelly writes, that adding to the cascade of legal troubles for broker-dealers that sold private placements for Medical Capital Holdings Inc., two banks have now sued several independent B-Ds that hawked the failed offerings.

It was reported that the Bank of New York Mellon Corp. and Wells Fargo Bank NA, were trustees for Medical Capital. In fact, both were sued in a class action in 2009 in U.S. District Court for the Central District of California after the Securities and Exchange Commission charged Medical Capital with fraud. But Bank of New York Mellon and Wells Fargo want the broker-dealers to pay up money if they are found liable in those class actions.

On April 29, the two banks filed separate lawsuits against the broker-dealers, including struggling Securities America Inc., claiming that the broker-dealers “breached their obligation to MedCap investors” by selling the product to investors for whom it was not a suitable investment, and failing to make proper disclosure of the notes’ risks. Bank of New York Mellon has sued 13 broker-dealers, seven of which are no longer in business. Wells Fargo has sued six firms, as well as Ameriprise Financial Inc., which owns Securities America, the biggest seller of Medical Capital notes. Not all broker-dealers that sold the product were included in the suit. “We believe the banks’ actions are unwarranted and baseless,” said Janine Wertheim, a spokeswoman for Securities America. “The wrongdoing in this case lies with the principals of Medical Capital, who have been accused of fraud by the SEC.”

Kelly writes that the plaintiffs in the class action against the two banks claimed in a 2010 amended complaint that the two trustees signed off on a request by Medical Capital executives to take $325 million in fees — despite documents for the Medical Capital notes stating that fees were not supposed to come from investor funds. From 2003 to 2008, dozens of independent broker-dealers sold notes of Medical Capital, which raised $2.2. billion. Securities America sold about $700 million of the product and last month agreed to settle with investors who sued the firm in a class action. Investors have lost more than $1 billion in principal, and regulators and the Medical Capital bankruptcy trustees have said the operation was a Ponzi scheme.

The banks’ suits against the B-Ds is at least the third time in the past year that broker-dealers that sold failed private placements or real estate deals have been sued by outside parties such as a trustee or receiver. Last June, the trustee overseeing the receivership of another failed series of private placements, Provident Royalties LLC, sued almost 50 broker-dealers seeking to claw back $285 million, including commissions.

And in November, the bankruptcy trustee for DBSI Inc., which packaged real estate deals and went bust in 2008, sued almost 100 broker-dealers looking to get back about $49 million from the firms.

If you or a family member have become a victim of the alleged fraudulent sale of private placements for Medical Capital Holdings, Inc. by your broker-dealer, call a Securities Arbitration Lawyer for a free consultation on how you could potentially recover your losses.  To speak with an attorney, call 888-760-6552, or visit www.stockmarketlawsuit.com. Soreide Law Group, PLLC., representing investors nationwide before FINRA  the Financial Industry Regulatory Authority.

b-d selling MedCap · Bank of New York Mellon Corp · Bank of NY Mellon Medical Capital · broker-dealer private placement fraud · broker-dealers breached obligations · DBSI Inc · elder abuse awareness · elder abuse in investments · failed private placements · Financial Industry Regulatory Authority · FINRA · FINRA arbitration · finra securities arbitration · fort lauderdale securities fraud lawyer · fort lauderdale securities lawyer · Ft. Lauderdale Securities Lawyer · high-risk private placements · MedCap · Medical Capital Holdings Inc · Medical Capital ponzi scheme · not suitable investments · Ponzi scheme · private placement fraud · private placement losses · private placements · Provident Royalties LLC · Provident Royalties Private Placements · SEC · SEC sues Medical Capital · Securities America Inc. · Securities and Exchange Commission · securities arbitraton lawyer · securities fraud · securities fraud lawyer · Soreide Law Group PLLC · stock broker fraud · Stock fraud lawyer · stock loss · stockbroker misconduct · targeting elderly investors · trustees for Medical Capital · unsuitable private placements · Wells Fargo Bank NA · Wells Fargo Medical Capital Holdings

Source: U.S. Bankruptcy court filings, Northern District of Texas, case # 09-33886

If you feel you have been an alleged victim of these broker-dealers and were sold Provident Royalties private placements, call a Securities Arbitration Lawyer for a free consultation on how to potentially recover your losses.  To speak with an attorney, call 888-760-6552, or visit www.stockmarketlawsuit.com. Soreide Law Group, PLLC., representing investors nationwide before FINRA  the Financial Industry Regulatory Authority.

advisory group equity servies ltd · afa financil group llc · american portfolios financial services inc · asset management strategies llc · ausdal financial partners inc · b-d failure to looking into private placements · barron moore inc · bd fraud · boker-dealer fraud · boogie investment group inc · Broker dealers selling private placements · broker-dealer private placement fraud · brookstone securities inc · callaway financial services inc · calton & associates inc · Capital Financial Services Inc · CapWest Securities Inc · chester harris & co · community bankers securities llc · crescent securities group · David Harris & Co Inc · DeWaay Financial Network LLC · e-planning.com securities inc · eagle one investments llc · elder abuse awareness · elder abuse in investments · empire financial group inc · empire securities corp · Financial Industry Regulatory Authority · FINRA · finra lawyer · finra securities arbitration lawyer · firms that sold provident royalties · First Allied Securities Inc. · fort lauderdale securities fraud lawyer · fort lauderdale securities lawyer · fraud · Ft. Lauderdale Securities Lawyer · Gk securities llc · grant bettingen inc · GunnAllen Financial Inc · Harrison Douglas Inc · high-risk private placements · Independent Financial group · INVEST Financial Corp · Investline securities llc · investment fraud · investors capital corp · j.p. turner & co llc · Jesup & Lamont · Kaiser & Co · Lars Soreide · Lighthouse Capital Corp · Main Stree Securities LLC · matheson securities llc · milkie ferguson investments inc · morrow wealth management · national securities corporation · newbridge securities corp · next financial group inc · Okoboji Financial Services Inc · Private Asset group inc · private placement bankruptcy · private placement fraud lawyer · private placement loss · private placement losses · private placements · Provident Asset Management · Provident Royalties · provident royalties broker dealers · Provident Royalties Private Placements · QA3 Financial Corp · Questar Capital Corp · reg d private placement · Securian Fianancial Services inc · Securities America Inc. · securities arbitraton lawyer · securities fraud lawyer · Securities Network llc · SII Investments Inc · Soreide Law Group PLLC · Sterling Enterprises Group Inc · stock broker fraud · Stock fraud lawyer · stock loss · Summit Brokerage Services Inc · targeting elderly investors · Unaffiliated broker-dealer · United securities alliance inc · Unity Equity Securities llc · waterford investor services inc · wedbush morgan securities inc · westpark capital inc · WFP Securities Corp · Wiliams Financial Group Inc · Workman Securities Corp.

Another article from Bruce Kelly of InvestmentNews.com, March 21st., 2011, says that Ameriprise Financial Inc. is taking preliminary steps to help its beleaguered independent broker-dealer subsidiary, Securities America, Inc.

This past Friday, Securities America’s chief financial officer, Kelly Windorski, testified in a federal court in Dallas that the firm could go bust if a federal judge did not approve a $21 million class action settlement. The judge rejected the settlement later in the day.

This class action is part of a litigation that Securities America is facing after its brokers sold $400 million in private placements from 2003 to 2009 that are now in default. The firm has almost $9 million in excess net capital on hand.

Kelly goes on in his article that it’s been widely debated in the industry whether Securities America’s corporate parent, Ameriprise, will step in and infuse the firm with cash. At the moment, the brokerage has dwindling resources, is spending $2 million a month on lawyers and could be in danger of violating its net-capital requirement if it suddenly loses a handful of arbitration claims investors have brought against the firm over allegedly bad private placements. Securities America’s statement gave no specifics about how much money Ameriprise would be willing to contribute to the firm, but a Securities America spokeswoman said the parent company has reached out to the beleaguered firm.

“Ameriprise has reached out to us to determine whether it can help the parties find a reasonable resolution for all constituents,” wrote Janine Wertheim, a spokeswoman for the broker-dealer, which has about 1,800 reps and advisers. “We hope to develop a process in the coming days that would facilitate exploration of such a resolution and to have a good sense by the end of the week.”

“While Ameriprise Financial has no obligation to participate in Securities America’s settlement discussions, we have reached out to Securities America to determine if we can help the parties find a reasonable resolution to all constituents,” Ameriprise said in a statement published on its investor relations website.

 Ameriprise said in its annual report that it was setting aside $40 million in reserves due to legal actions stemming from brokers at Securities America selling private placements of Medical Capital Holdings Inc. and Provident Royalties LLC. These were sold by dozens of independent broker-dealers in the last decade, the two series of private placements went into default in 2009 and the sponsor companies were later charged with fraud by the SEC. Securities America was by far the largest seller of Medical Capital notes, with brokers selling about $700 million of the product.

The InvestmentNews article said that Ameriprise previously had reached a proposed $28 million settlement with the class action plaintiffs suing Securities America. That proposed settlement is a separate fund from Securities America’s.

Federal Judge W. Royal Furgeson Jr. temporarily halted three arbitration claims from investors suing Securities America in order to weigh Securities America’s $21 million proposed settlement last month. Under the terms of that deal, the arbitration claims would have been rolled into the class action. Mr. Furgeson’s decision pushes one of two class actions, Billitteri v Securities America, et al., back to where it originated in U.S. District Court in the Central District of California. The case was moved to Dallas and landed before Mr. Furgeson this winter because he is overseeing the class action claim against Securities America and other broker-dealers that sold Provident Royalties investments.

If you feel you have been a victim of the alleged broker-dealer private placement  schemes of  Securities America Financial, Inc., Ameriprise Financial Inc ., Medical Capital Holdings, Inc., or any other broker-dealer, call a Securities Arbitration Lawyer for a free consultation on how to recover your losses.  To speak with an attorney, call 888-760-6552, or visit www.stockmarketlawsuit.com. Soreide Law Group, PLLC., representing investors nationwide before FINRA  the Financial Industry Regulatory Authority.

Ameriprise · Ameriprise bailing out Securities America · Ameriprise Financial Inc · broker-dealer private placement fraud · Financial Industry Regulatory Authority · FINRA · FINRA arbitration · finra lawyer · fort lauderdale securities fraud lawyer · fort lauderdale securities law firm · fort lauderdale securities lawyer · Ft. Lauderdale Securities Lawyer · investment fraud · Medical Capital Holdings Inc · private placement fraud · private placement losses · private placement of securities · private placements · private placements in default · Provident Royalties · Securities America · Securities America Inc. · securities arbitration · securities arbitraton lawyer · securities fraud lawyer · Soreide Law Group PLLC · stock broker fraud · Stock fraud lawyer · stockbroker misconduct

In a March 2, 2011, article from Investment News, Bruce Kelly writes that Ameriprise Financial Inc. has reached a $27 million settlement with investors who bought private placements that have gone bust from reps at its independent broker-dealer subsidiary, Securities America Inc., according to an attorney with knowledge of the matter.

Securities America is also being sued by securities regulators from Massachusetts and Montana but the status of those suits is not clear in the light of the proposed settlements. Mr. Furgeson will hold a hearing in federal court in Dallas on the proposed settlements on March 18. Lawyers for the plaintiffs in arbitration plan to argue vigorously against any settlement that would freeze investors’ arbitration claims against Securities America.

The InvestmentNews article states that the proposed settlement, which must be approved by a federal judge later this month to become final, comes two weeks after Securities America reached a $21 million potential settlement with the class action plaintiffs who sued Securities America and Ameriprise in 2009.

The article goes on to state that in one allegation from the suit, C. Richard Toomey, et al. v. Securities America Inc., et al, plaintiffs claimed that Securities America handed private placement memorandum to clients that contained untrue statements about the deals and omitted other material information about the deals.

This is all part of a labyrinth of litigation before federal judge W. Royal Furgeson Jr. in Dallas, stemming from dozens of independent broker-dealers, including Securities America, selling two series of private placement deals that have left investors with tens of millions of dollars of losses.

The Securities and Exchange Commission charged both Medical Capital and Provident Royalties with fraud in 2009.

Chris Reese, a spokesman for Ameriprise, said on Wednesday evening he could not confirm or deny the settlement. In its annual report earlier this week, Ameriprise said Securities America clients were facing almost $400 million in losses from the Medical Capital and Provident investments, and the firm also said it had set aside about $40 million in legal reserves for the claims.

It was noted that a key part of the potential Securities America settlement is the fact that it requires investors who have sued the firm through arbitration under the Financial Industry Regulatory Authority Inc. will have those claims halted. Investors would become part of the class. This has infuriated some investors, along with their attorneys, who want their claims to go forward through arbitration with hopes of winning 100 cents on the dollar, plus the potential for damages.

The firm was dealt a costly legal blow on New Year’s Eve when a Finra arbitration panel awarded almost $1.2 million in damages and legal fees to a client who sued the firm and a broker over the sale of Medical Capital private placements. The award included $250,000 in punitive damages.

“A class action settlement treats everyone fairly,” Mr. Girard said. He added that some plaintiff’s attorneys representing clients in Finra arbitration have a “conflict of interest” over the matter because they have clients at the front and the back of the long line of litigation against Securities America. Those at the back of the line run the risk of getting nothing if the firm runs out of money, he said.

InvestmentNews states that threat is substantial. Small to mid-sized independent broker-dealers that sold high risk private placements have gone out of business due to lawsuits and legal costs over the past two years. None have been as substantial as Securities America, which has about 1,800 reps and advisers who generated about $500 million in fees and commissions last year.

If you feel you have been a victim of the alleged broker-dealer private placement fraudulent schemes of  Ameriprise Financial Inc ., Securities America, Inc., or any other broker-dealer, call a Securities Arbitration Lawyer for a free consultation on how to recover your losses.  To speak with an attorney, call 888-760-6552, or visit www.stockmarketlawsuit.com. Soreide Law Group, PLLC., representing investors nationwide before FINRA  the Financial Industry Regulatory Authority.

Ameriprise Financial Inc · Financial Industry Regulatory Authority · FINRA · FINRA arbitration · finra lawyer · finra securities arbitration · finra securities arbitration lawyer · fraud · Ft. Lauderdale Securities Lawyer · investment fraud · life insurance lawyer · Medical Capital · private placement fraud · private placement losses · private placement of securities · private placements · Provident Royalties · SEC · Securities America · Securities America Inc. · Securities and Exchange Commission · securities arbitration · securities arbitraton lawyer · securities fraud lawyer · Soreide Law Group PLLC · Stock fraud lawyer · stockbroker misconduct · unregistered private placements

It was reported by Bruce Kelly for InvestmentNews that four hundred registered reps are scrambling for a new home after learning that their broker-dealer, QA3 Financial Corp., will close at the end of this week

“It’s like a smash and grab for these guys,” said Shawn Smith, principal of Financial Advisor Placement Services, a recruiting firm. “It’s a shame it happened. There’s a lot of good advisers at QA3.”

Smith said some reps had seen the firm’s closing coming and had made contingency plans for finding a new broker-dealer. He added that some reps had formed large “marketing” groups, meaning a group of dozens of reps working under a common banner. Such groups have better leverage in negotiating terms with a broker-dealer and can command a higher payout, he said.

Another recruiter pointed to the fact that the reps should quickly find new firms because they all work with Pershing LLC, the industry’s biggest clearing firm. The use of Pershing “gives the advisers a lot of options and will help them transition without much downtime or service interruption,” said Brad Fay, president of IBD Placement and Recruiting Services.

 Steve Wild, QA3′s owner and CEO, wrote in an e-mail that landed in brokers’ inboxes more than an hour after the market close Friday, “In light of the arbitration award rendered against QA3 on Jan. 14, and the fact that our errors and omissions carrier has not yet provided coverage set forth in our policy, we have made the difficult decision to cease conducting business as a broker-dealer effective as the close of business on Feb. 11.”

QA3, which at its peak did $50 million per year in gross revenue, will be one of the highest-profile independent broker-dealers to exit the business in the past year.

According to InvestmentNews, about two dozen firms last year decided to shut down or were forced to shut down, facing rising legal costs and a tough regulatory environment. According to a number of industry sources, QA3 had been in discussions with other independent broker-dealers about a potential sale of the firm’s assets, but ultimately, a deal failed to materialize.

Mr. Wild, one of the most successful entrepreneurs in the independent-contractor-broker-dealer industry, sold Securities America Inc. to American Express Co. in a time when insurance companies were paying premiums for independent broker-dealers in 1998.

QA3 has been one of the leading sellers of Regulation D private placements in the last decade. Two of those deals, Medical Capital Holdings Inc. and Provident Royalties LLC, face fraud charges from the Securities and Exchange Commission. The firm tried to raise money in 2009, offering Regulation D private-placement notes. According to filings with the SEC, the firm was looking to sell $3 million in debt to complete acquisitions. The commission also indicated that the brokerage had raised no money for the deal as of July 2009.

In September, QA3 claimed it faced bankruptcy because of a dispute with its insurance carrier over the amount of coverage the B-D has for legal claims stemming from its sale of private placements.

QA3 claimed that it has coverage for $7.5 million in legal claims, damages and expenses. Its carrier, Catlin Specialty Insurance Co., said that the coverage is capped at $1 million.

In January, QA3 lost a $1.6 million arbitration award to an elderly couple who invested in real estate deals that went bust. It appears that that decision was the arbitration award to which Mr. Wild was referring in his e-mail to brokers late Friday.

It is noted that the regulators with the Financial Industry Regulatory Authority Inc. have been watching the firm’s levels of net capital quite closely as of late, as losses of securities arbitration claims have to be recorded in a firm’s net capital calculations. According to its 2009 audited financial report, QA3 had $118,000 of excess net capital at the end of that year.

QA3 faces other lawsuits and arbitrations due to different failed private placements.

If you have been a victim of the alleged fraudulent schemes of  QA3 Financial Corporation, call a Securities Arbitration Lawyer for a free consultation on how to recover your losses.  To speak with an attorney, call 888-760-6552, or visit www.stockmarketlawsuit.com. Soreide Law Group, PLLC., representing investors nationwide before FINRA  the Financial Industry Regulatory Authority.

Financial Industry Regulatory Authority · FINRA · FINRA arbitration · finra lawyer · finra securities arbitration · finra securities arbitration lawyer · fraud · Ft. Lauderdale Securities Lawyer · independent broker-dealers · insurance companies buying brokerages · investment fraud · life insurance lawyer · Medical Capital Holdings Inc · Pershing LLC · private placement fraud · private placement losses · private placemnts · Provident Royalties LLC · QA3 · QA3 Bankruptcy · QA3 Financial Corp · Regulation D private placements · SEC · Securities America Inc. · Securities and Exchange Commission · securities arbitration · securities arbitraton lawyer · securities fraud lawyer · Soreide Law Group PLLC · Steve Wild · Steve Wild CEO QA3 · Stock fraud lawyer · stockbroker misconduct · unauthorized trades

On New Years’ Eve, Securities America Inc. was dealt a costly legal blow when a Finra arbitration panel awarded almost $1.2 million in damages and legal fees to a client who sued the firm and a broker over the sale of private placements that regulators have alleged were fraudulent.

The award, from three Financial Industry Regulatory Authority Inc. arbitrators, included compensatory damages of $734,000 and punitive damages of $250,000, plus attorney and expert witness fees of $171,000. The claimant, Josephine Wayman, also sued Randall Ray Talbott, a Newport Beach, Calif.-based rep, who is also liable for the award, according to the arbitrators’ decision, which was filed with Finra Dec. 31.

It is uncommon for punitive damages  in Finra arbitration awards.

“This is a powerful win for the claimants,” said a plaintiff’s attorney who represents more than 100 clients in similar arbitration claims seeking more than $35 million in damages against Securities America. The punitive damages in this award shows that the three arbitrators were “shocked” by Securities America’s action involving Medical Capital notes, he said.

After checking his profile on Finra’s BrokerCheck system, Mr. Talbott has 11 other pending customer disputes involving the sale of Medical Capital notes, but he is not named as a defendant in many of the arbitration cases. When asked about the award, Mr. Talbott said, “I don’t know anything about it.” He added that the matter was “very unfortunate.”

Securities America has tried to pin blame for the losses on Medical Capital Holdings Inc., the issuer of the private placements.

Securities America could be on the hook for millions of dollars more in legal damages involving the sale of private placements before the market collapse of 2008. The securities divisions of Massachusetts and Montana are also suing the firm.

“If there’s a problem here, Medical Capital is to blame, not Securities America,” Bruce Bettigole, a partner at Sutherland Asbill & Brennan LLP who is serving as lead attorney for the broker-dealer, said during a September hearing with before Massachusetts Securities Division.

In November, Jim Nagengast, the firm’s CEO said, “We feel very strongly we did industry-leading due diligence and are vigorously defending” the firm and its advisers.

This particular arbitration award appears to be the first involving Securities America’s sale of private placements issued by Medical Capital, which the Securities and Exchange Commission charged with fraud in 2009. Dozens of independent broker-dealers sold private Medical Capital notes, which raised $2.2 billion from 2003 to 2008. Securities America was by far the biggest seller of the Medical Capital product, with 400 brokers selling almost $700 million of notes. Medical Capital is in bankruptcy, and the receiver estimated that about half of investors’ money, $1.1 billion, is gone.

It was noted that a spokesman for Ameriprise, said the firm had no comment.

As is common in Finra arbitration awards, the decision gives no reasoning for the award. However, the arbitrators did offer comments about their decision, a point of great interest to other clients suing Securities America.

Securities America, with about 1,900 reps and advisers, is owned by Ameriprise Financial Inc., one of the largest retail brokerage firms in the country. “The award was based on the specific facts of this investor’s case, and we disagree with the outcome,” wrote Janine Wertheim, a company spokeswoman, in an e-mail. “Securities America does not believe it acted inappropriately in the sale of these investments.”

“The panel’s decision is based on what was actually known by Randall Talbott and Securities America Inc. at the relevant times and is not based on what additional information could or could not have been discovered by respondents regarding the subject investments or the company offering the investments,” according to the award. “The decision is based on what was actually known by Randall Talbott and Securities America Inc. at the relevant times.”

This information was obtained from Investment News’ website in an article by Bruce Kelly.

If you feel you have been a victim of these alleged fraudulent schemes of  Securities America, Inc., Randall Ray Talbott, Ameriprise Financial, Inc., or Medical Capital Holdings, Inc., call a Securities Arbitration Lawyer for a free consultation on how to recover your losses.  To speak with an attorney, call 888-760-6552, or visit www.stockmarketlawsuit.com. Soreide Law Group, PLLC., representing investors nationwide before FINRA  the Financial Industry Regulatory Authority.

Ameriprise Financial Inc · Financial Industry Regulatory Authority · FINRA · FINRA arbitration · FINRA brokercheck · finra lawyer · finra securities arbitration · Florida Securities Lawyer · Ft. Lauderdale Securities Lawyer · investment fraud · Medical Capital Holdings Inc · Medical Capital notes · private placements · Randall Ray Talbott · Securities America · Securities America Inc. · securities arbitration · securities arbitraton lawyer · Stock fraud lawyer